Moreover, E-cadherin can be directly O-GlcNAcylated in breast cancer cells during drug-induced apoptosis, and this modification inhibits its transport to the cell surface, thereby decreasing cell-cell interactions and promoting EMT. The gene discussed is CDH1; the disease is breast carcinoma.